Dr. Fleurence is a researcher pharmacist at Baylor College of Medicine. Under the mentorship of Dr. Andras Heczey, a past Powered by Pablove grantee, he is exploring new therapy for pediatric liver cancer using the body’s own immune system. In Dr. Fleurence’s own words: Hepatoblastoma and hepatocellular carcinoma are the most common liver cancers in…
A physician scientist at Children’s Hospital Boston, Dr. Grant Rowe MD PhD is a very busy man! He sees patients and works in a lab. Dr. Rowe is studying leukemia in infants, which is often a very aggressive disease. His Powered by Pablove research project hopes to illuminate how this disease develops and grows so…
A scientific researcher at CHLA, Dr. Laura Perin PhD is using cutting edge methods to study kidney development. With her Powered by Pablove research grant, she hopes to improve our understanding of how kidney tumors develop in children. In Dr. Perin’s own words: Wilms’ Tumor (WT), a pediatric cancer known as nephroblastoma, accounts for 95%…
Dr. Kumar is a research investigator at the University of Michigan studying the proteins on Ewing’s sarcoma cells. The objective of his Powered by Pablove research grant is to identify targets for less toxic and more effective treatment options for this aggressive bone tumor. This grant is funded by Peloton Magazine. In Dr. Kumar’s own…
Dr. Lemberg is a pediatric oncologist and lab researcher at John’s Hopkins University School of Medicine. She just received her second year of funding from Pablove to continue researching a novel therapy for Malignant Peripheral Nerve Sheath Tumors. Her project focuses on a novel agent developed at John’s Hopkins that works differently than conventional chemotherapy,…
At University of California San Francisco, Dr.Clay Gustafson is tackling some of the most difficult to treat pediatric cancers; tumors such as neuroblastoma that are driven by the MYC family of proteins. Dr. Gustafson’s Powered by Pablove Seed Grant will allow him to explore a new therapy that shows great promise for treating these tumors….
Understanding how germ cell tumors arise is tricky since these tumors start very early in life; perhaps even in utero. A creative physician-scientist at UCLA.,Dr. Joanna Gell has helped developed a new way to study these tumors using stem cells. With a greater understanding of how these tumors form, new therapies to treat this cancer…
Dr. Ott is a bright junior investigator at Massachusetts General Hospital. The aim of his Powered by Pablove seed grant project is to identify proteins critical for the survival of T-cell Leukemia cells as well as new drug agents that can be effective in treating this difficult disease.
